Despite the strong anti-tumor effect of C-KIT inhibitors, MM patients who respond to the inhibiting agents well at the beginning will frequently experience a brief period of disease response before developing resistance to KIT inhibitors that eventually leads to progressive disease (152, 153). The gene discussed is KIT; the disease is neoplasm.